Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: the different roles of FGF21
Open Access
- 26 March 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-9
Abstract
Increased fibroblast growth factor 21 (FGF21) levels have been found in patients with metabolic syndrome (MetS). MetS is also associated with cognitive decline. However, the correlation between FGF21 and cognitive decline in elderly and nonelderly MetS patients has not been investigated. 116 non-elderly patients (age <65 years old) and 96 elderly patients (≥65 years old) with MetS were enrolled. Blood samples for FGF21 were collected from all participants after 12-hour fasting. Cognitive function was assessed using the Montreal cognitive assessment (MoCA) test. The MoCA score was negatively associated with age and was different among different levels of education in these MetS patients. In the non-elderly group, body mass index (BMI) showed positively correlated with MoCA score while, FGF21 level and HbA1C were negatively associated with the MoCA score in non-elderly MetS patients. BMI was the only factor which showed a negative correlation with the MoCA score in elderly MetS patients. This study demonstrated that FGF21 level was independently associated with cognitive impairment in non-elderly patients but not in elderly patients. The possible role of FGF21 level in cognitive impairment in non-elderly should be confirmed in a prospective study.Keywords
This publication has 49 references indexed in Scilit:
- Prevalence of metabolic syndrome components among the elderly using three different definitions: A cohort study in FinlandScandinavian Journal of Primary Health Care, 2012
- FGF21 and the Second Coming of PPARγCell, 2012
- Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesityDiabetes/Metabolism Research and Reviews, 2011
- Metabolic Syndrome, Brain Magnetic Resonance Imaging, and CognitionDiabetes Care, 2010
- Prevalence and gender distribution of the metabolic syndromeDiabetology & Metabolic Syndrome, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 studyBMC Public Health, 2007
- Metabolic Syndrome and Dementia Risk in a Multiethnic Elderly CohortDementia and Geriatric Cognitive Disorders, 2007
- Cognitive Dysfunction Is Associated With Poor Diabetes Control in Older AdultsDiabetes Care, 2006
- A meta-analysis of the association between adherence to drug therapy and mortalityBMJ, 2006